Business Context and Reporting Period
This Form 8-K is a current report filed by Fluidigm Corporation (not Standard BioTools Inc.) on February 5, 2015. The filing serves to announce the company's financial results for the fourth quarter and full year ended December 31, 2014. The actual financial data is contained in a press release furnished as Exhibit 99.1, which is not included in the provided text.
Key Financial Metrics
The provided filing text does not contain specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These metrics are referenced as being reported in the attached press release (Exhibit 99.1) but are not present in the source document text.
Material Changes
The filing text does not provide specific details regarding material changes versus prior periods. It only confirms that results for the fourth quarter and full year 2014 were issued.
Guidance, Outlook, and Risks
The text does not include management commentary, forward-looking guidance, specific risks, or contingencies. It notes that the information furnished under Item 2.02 and the attached exhibit shall not be deemed "filed" for purposes of Section 18 of the Exchange Act or incorporated by reference unless expressly stated.
Investor Verification Checklist
- Verify the correct registrant name: The filing is for Fluidigm Corporation, not Standard BioTools Inc.
- Locate and review Exhibit 99.1 (Press Release dated February 5, 2015) to obtain actual revenue, earnings, and cash flow figures.
- Confirm the specific details of the fourth quarter and full-year 2014 performance in the external press release.
- Note that the 8-K text itself does not incorporate the financial data by reference for liability purposes under Section 18.